CAR T-cell therapy (FamiCord Tx)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCAR T-cell therapy (FamiCord Tx)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionT lymphocytes stimulantsImmunostimulants

TargetsUpdating

Therapy Area/IndicationsLymphoma, Large B-Cell, Diffuse

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPolish Stem Cell Bank SA

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPolish Stem Cell Bank SA

Active IndicationsN/A

Inactive IndicationsLymphoma, Large B-Cell, Diffuse

Other Information

ATC CodeN/A